Table 2.
Characteristics of Study Treatment Received
| Low Family Impairment |
High Family Impairment |
||||||
|---|---|---|---|---|---|---|---|
| Characteristic | Total Sample (N = 91) | Pharmacotherapy (N=15) | Family Therapy (N = 7) | Psychoeducational Group (N = 9) | Pharmacotherapy (N=14) | Family Therapy(N = 25) | Psychoeducational Group (N = 21) |
| Early dropout, < 2 months, N% | 9 (10) | 2 (13) | 2 (29) | 0 (0) | 1 (7) | 1 (4) | 3 (14) |
| Completed ≥ 6 months of randomized treatment, N (%) | 59 (65) | 12 (80) | 4 (57) | 7 (78) | 7 (50) | 16 (64) | 13 (62) |
| Month of randomized treatment discontinuation, mean (SD) | 14.8 (11 .5) | 17.3 (11.2) | 13.6 (13.7) | 13.6 (9.7) | 11.3 (11.6) | 15.4 (11.6) | 14.6 (12.0) |
| Completed 28 months of randomized treatment, N (%) | 33 (36) | 7 (47) | 3 (43) | 2 (22) | 3 (21) | 10 (40) | 8 (38) |
| Mood stabilizer, adequate dose, N (%) | 82 (90) | 13 (87) | 6 (86) | 9 (100) | 11 (79) | 23 (92) | 20 (95) |
| Antidepressant use, N (%) | 46 (51) | 5 (33) | 3 (43) | 6 (67) | 6 (43) | 16 (64) | 10 (48) |
| Neuroleptic use, N(%) | 72 (79) | 14 (93) | 5 (71) | 8 (89) | 12 (86) | 18 (72) | 15 (71) |
| No. of pharmacotherapy visits, mean (SD) | 12.8 (8.9) | 13.5 (7.7) | 16.7 (15.6) | 13.0 (7.4) | 9.9 (8.4) | 13.7 (8.9) | 11.3 (8.5) |
| No. of family therapy visits, mean (SD) | 11.9 (12.9) | NA | 12.8 (12.1) | NA | NA | 11.6 (12.1) | NA |
| No. of psychoeducational group meetings, mean (SD) | 3.9 (2.5) | NA | NA | 4.6 (2.2) | NA | NA | 3.7 (2.6) |
Abbreviation: NA = not applicable.